Transgene
Clinical trials sponsored by Transgene, explained in plain language.
-
Custom-Made vaccine aims to keep head and neck cancer from coming back
Disease control OngoingThis study tests a personalized immunotherapy called TG4050 in 80 people with newly diagnosed, advanced head and neck cancer. Participants receive the treatment after standard therapy to see if it safely delays the cancer's return. The approach targets unique mutations in each pa…
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated May 26, 2026 08:40 UTC
-
New combo therapy shows promise against HPV-Driven cancers
Disease control OngoingThis study tests a combination of two drugs, TG4001 and avelumab, in people with advanced cancers caused by HPV-16. The goal is to see if the combination can shrink tumors or slow disease progression better than avelumab alone. About 143 adults with cervical, anal, penile, or vul…
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated May 26, 2026 08:34 UTC